Trial Profile

Pilot Trial of Acute Effect of Lorcaserin to Reduce Patient-Reported Symptoms of Taxane- and Oxaliplatin-Induced Peripheral Neuropathy

Status: Withdrawn prior to enrolment

Phase of Trial: Phase I

Latest Information Update: 20 Jan 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Lorcaserin (Primary)
Indications Chemotherapy-induced damage; Peripheral neuropathies
Focus Therapeutic Use

Most Recent Events

14 Jan 2021 Status changed from not yet recruiting to withdrawn prior to enrolment due to PI decision.
19 Sep 2020 Planned initiation date changed from 1 Aug 2020 to 1 Nov 2020.
03 Jun 2020 Planned initiation date changed from 31 Jan 2020 to 1 Aug 2020.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com